ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
25.88
+0.45 (1.77%)
At close: Dec 3, 2025, 4:00 PM EST
25.97
+0.09 (0.35%)
After-hours: Dec 3, 2025, 5:53 PM EST

ACADIA Pharmaceuticals Stock Forecast

Stock Price Forecast

The 21 analysts that cover ACADIA Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $29.24, which forecasts a 12.98% increase in the stock price over the next year. The lowest target is $17 and the highest is $39.

Price Target: $29.24 (+12.98%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$17$29.24$29$39
Change-34.31%+12.98%+12.06%+50.70%

Analyst Ratings

The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy445666
Buy788888
Hold777666
Sell000000
Strong Sell011111
Total182021212121

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Mizuho
Mizuho
Hold
Maintains
$24$29
HoldMaintains$24$29+12.06%Dec 2, 2025
JP Morgan
JP Morgan
Buy
Maintains
$33$31
BuyMaintains$33$31+19.78%Nov 17, 2025
RBC Capital
RBC Capital
Buy
Maintains
$34$32
BuyMaintains$34$32+23.65%Nov 6, 2025
Needham
Needham
Strong Buy
Maintains
$28$29
Strong BuyMaintains$28$29+12.06%Nov 6, 2025
Citigroup
Citigroup
Strong Buy
Initiates
$33
Strong BuyInitiates$33+27.51%Oct 21, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.10B
from 957.80M
Increased by 15.16%
Revenue Next Year
1.23B
from 1.10B
Increased by 11.42%
EPS This Year
0.83
from 1.36
Decreased by -38.73%
EPS Next Year
0.82
from 0.83
Decreased by -1.91%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
441.76M484.15M517.24M726.44M957.80M1.10B1.23B
Revenue Growth
30.28%9.60%6.83%40.45%31.85%15.16%11.42%
EPS
-1.79-1.05-1.34-0.371.360.830.82
EPS Growth
------38.73%-1.91%
Forward PE
-----31.0631.66
No. Analysts
-----2222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
High1.1B1.4B
Avg1.1B1.2B
Low1.1B1.1B

Revenue Growth

Revenue Growth202520262027202820292030
High
19.2%
25.4%
Avg
15.2%
11.4%
Low
9.7%
2.9%

EPS Forecast

EPS202520262027202820292030
High1.031.25
Avg0.830.82
Low0.540.40

EPS Growth

EPS Growth202520262027202820292030
High
-24.3%
50.0%
Avg
-38.7%
-1.9%
Low
-60.4%
-52.4%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.